Literature DB >> 10074812

The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin.

B Bohus1, D de Wied.   

Abstract

Behavioral neuroscience is using more and more gene knockout techniques to produce animals with a specific deletion. These studies have their precedent in nature. A mutation may result in a limited genetic defect, as seen in the vasopressin (VP) deficiency in the Brattleboro rat. The mutation is in a single pair of autosomal loci, and the sequences of VP gene from wild-type and homozygous Brattleboro rats are identical except for a single nucleotide deletion in the second exon. The deletion results in the synthesis of an altered VP precursor that is unable to enter the secretory pathway. The genetic disturbance results in a central diabetes insipidus comparable to that found in humans. Starting with our work during the early 1970s we found that the genetic defect in the availability of VP causes deficits in central nervous system (CNS) functions. Behavioral processes from cognition to drug tolerance appeared to be disturbed by the absence of VP, but not all behaviors are affected. The specificity of the absence of VP in causing behavioral deficits is shown in many cases. However, certain deficits are due to genetic factors other than the deletion of the VP gene. The picture is further complicated by differences in testing conditions, the absence of proper controls, i.e. heterozygous and wild-type Brattleboro rats, sex, compensation phenomena, and the absence of neuropeptides co-localized with VP. Interestingly, an age dependent spontaneous shunt to a heterozygous phenotype in vasopressinergic neurons might also compensate for the disturbance. Accordingly, findings in knockout animals should be interpreted with caution. One should realize that brain functions are modulated by multiple neuropeptides and that neuropeptides possess multiple CNS effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10074812     DOI: 10.1016/s0079-6123(08)61593-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  7 in total

1.  In memoriam Béla Bohus 1936-2000.

Authors:  David De Wied
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

2.  Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy.

Authors:  D Feifel; P D Shilling; G Melendez
Journal:  J Psychopharmacol       Date:  2010-11-24       Impact factor: 4.153

Review 3.  Vasopressin: behavioral roles of an "original" neuropeptide.

Authors:  Heather K Caldwell; Heon-Jin Lee; Abbe H Macbeth; W Scott Young
Journal:  Prog Neurobiol       Date:  2007-11-04       Impact factor: 11.685

Review 4.  Advances in novel molecular targets for antidepressants.

Authors:  Qingzhong Wang; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-16       Impact factor: 5.067

5.  Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study.

Authors:  Negar Firouzabadi; Nima Ghazanfari; Ali Alavi Shoushtari; Nasrallah Erfani; Farshid Fathi; Mozhdeh Bazrafkan; Ehsan Bahramali
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

Review 6.  The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability.

Authors:  Bojana Savić; David Murphy; Nina Japundžić-Žigon
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

7.  A hypomorphic vasopressin allele prevents anxiety-related behavior.

Authors:  Mirjam Bunck; Ludwig Czibere; Charlotte Horvath; Cornelia Graf; Elisabeth Frank; Melanie S Kessler; Chris Murgatroyd; Bertram Müller-Myhsok; Mariya Gonik; Peter Weber; Benno Pütz; Patrik Muigg; Markus Panhuysen; Nicolas Singewald; Thomas Bettecken; Jan M Deussing; Florian Holsboer; Dietmar Spengler; Rainer Landgraf
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.